BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35271413)

  • 21. ABVD-Based Therapy for Hodgkin Lymphoma in Children and Adolescents: Lessons Learnt in a Tertiary Care Oncology Center in a Developing Country.
    Jain S; Kapoor G; Bajpai R
    Pediatr Blood Cancer; 2016 Jun; 63(6):1024-30. PubMed ID: 26855007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD.
    Albano D; Patti C; Matranga D; Lagalla R; Midiri M; Galia M
    Eur J Radiol; 2018 Jun; 103():90-98. PubMed ID: 29803392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET-CT-documented First Remission.
    Glober G; Gunther J; Fang P; Milgrom S; Korivi BR; Jensen CT; Wagner-Bartak NA; Ahmed S; Lee HJ; Nair R; Steiner R; Parmar S; Iyer S; Westin J; Fayad L; Rodriguez MA; Neelapu S; Nastoupil L; Flowers CR; Dabaja BS; Pinnix CC
    Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):533-541. PubMed ID: 32291233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy.
    Sher DJ; Mauch PM; Van Den Abbeele A; LaCasce AS; Czerminski J; Ng AK
    Ann Oncol; 2009 Nov; 20(11):1848-53. PubMed ID: 19541793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky limited-stage classical Hodgkin lymphoma.
    Abramson JS; Arnason JE; LaCasce AS; Redd R; Barnes JA; Sokol L; Joyce R; Avigan D; Neuberg D; Takvorian RW; Hochberg EP; Bello CM
    Blood; 2019 Aug; 134(7):606-613. PubMed ID: 31186274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Children and Adolescent Hodgkin Lymphoma in Argentina: Long-term Results After Combined ABVD and Restricted Radiotherapy.
    Zubizarreta PA; Alfaro E; Guitter M; Sanchez La Rosa C; Galluzzo ML; Millán N; Fiandrino F; Felice MS
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):602-608. PubMed ID: 28902084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posttreatment PET/CT Rather Than Interim PET/CT Using Deauville Criteria Predicts Outcome in Pediatric Hodgkin Lymphoma: A Prospective Study Comparing PET/CT with Conventional Imaging.
    Bakhshi S; Bhethanabhotla S; Kumar R; Agarwal K; Sharma P; Thulkar S; Malhotra A; Dhawan D; Vishnubhatla S
    J Nucl Med; 2017 Apr; 58(4):577-583. PubMed ID: 27754902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial.
    Georgi TW; Kurch L; Hasenclever D; Warbey VS; Pike L; Radford J; Sabri O; Kluge R; Barrington SF
    PLoS One; 2020; 15(4):e0231027. PubMed ID: 32240248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD × two cycles followed by FDG-PET/CT restaging and 20 Gy of involved-site radiotherapy.
    Kamran SC; Jacene HA; Chen YH; Mauch PM; Ng AK
    Leuk Lymphoma; 2018 Jun; 59(6):1384-1390. PubMed ID: 28937297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.
    Kluge R; Chavdarova L; Hoffmann M; Kobe C; Malkowski B; Montravers F; Kurch L; Georgi T; Dietlein M; Wallace WH; Karlen J; Fernández-Teijeiro A; Cepelova M; Wilson L; Bergstraesser E; Sabri O; Mauz-Körholz C; Körholz D; Hasenclever D
    PLoS One; 2016; 11(3):e0149072. PubMed ID: 26963909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients.
    Ciammella P; Filippi AR; Simontacchi G; Buglione M; Botto B; Mangoni M; Iotti C; Merli F; Marcheselli L; Bisi G; Ricardi U; Versari A
    Br J Radiol; 2016; 89(1061):20150983. PubMed ID: 27022777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A single-center retrospective analysis of 85 children and adolescents with limited-stage Hodgkin lymphoma].
    Wu B; Wang J; Zhu J; Zhen ZZ; Lu SY; Sun FF; Huang JT; Sun XF
    Zhonghua Xue Ye Xue Za Zhi; 2020 Aug; 41(8):649-654. PubMed ID: 32942818
    [No Abstract]   [Full Text] [Related]  

  • 33. Consolidation Radiation Therapy for Patients With Advanced Hodgkin Lymphoma in Complete Metabolic Response According to PET-CT or Gallium Imaging.
    Song EJ; Torok J; Wu Y; Chino J; Prosnitz LR; Beaven AW; Kelsey CR
    Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):145-151. PubMed ID: 29358045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treating early-stage Hodgkin lymphoma in resource-limited settings: InPOG-HL-15-01 experience.
    Mahajan A; Singh M; Bakhshi S; Jain S; Radhakrishnan V; Verma N; Seth R; Arora RS; Dinand V; Kalra M; Mandal P; Kapoor G; Sajid M; Thulkar S; Arora A; Taluja A; Chandra J
    Pediatr Blood Cancer; 2021 Oct; 68(10):e29219. PubMed ID: 34291860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy.
    Gandikota N; Hartridge-Lambert S; Migliacci JC; Yahalom J; Portlock CS; Schöder H
    Cancer; 2015 Jun; 121(12):1985-92. PubMed ID: 25739719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early chemotherapy de-escalation strategy in patients with advanced-stage Hodgkin lymphoma with negative positron emission tomography scan after 2 escalated BEACOPP cycles.
    Długosz-Danecka M; Szmit S; Kocurek A; Koźlik P; Giza A; Zimowska-Curyło D; Małkowski B; Sowa-Staszczak A; Kużdżał J; Jurczak W
    Pol Arch Intern Med; 2019 Apr; 129(4):259-266. PubMed ID: 30945698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hodgkin Lymphoma in Adolescent and Young Adults: Real-World Data from a Single Tertiary Cancer Center in India.
    Nayak L; Jain H; Bonda A; Epari S; Laskar S; Gokarn A; Shet T; Gujral S; Khanna N; Bagal B; Punatar S; Goda J; Thorat J; Rengaraj K; Sengar M
    J Adolesc Young Adult Oncol; 2021 Oct; 10(5):581-587. PubMed ID: 33090916
    [No Abstract]   [Full Text] [Related]  

  • 38. 18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma.
    Cerci JJ; Pracchia LF; Linardi CC; Pitella FA; Delbeke D; Izaki M; Trindade E; Soares J; Buccheri V; Meneghetti JC
    J Nucl Med; 2010 Sep; 51(9):1337-43. PubMed ID: 20720036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation.
    Metzger ML; Link MP; Billett AL; Flerlage J; Lucas JT; Mandrell BN; Ehrhardt MJ; Bhakta N; Yock TI; Friedmann AM; de Alarcon P; Luna-Fineman S; Larsen E; Kaste SC; Shulkin B; Lu Z; Li C; Hiniker SM; Donaldson SS; Hudson MM; Krasin MJ
    J Clin Oncol; 2021 Jul; 39(20):2276-2283. PubMed ID: 33826362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group.
    Fuchs M; Goergen H; Kobe C; Kuhnert G; Lohri A; Greil R; Sasse S; Topp MS; Schäfer E; Hertenstein B; Soekler M; Vogelhuber M; Zijlstra JM; Keller UB; Krause SW; Wilhelm M; Maschmeyer G; Thiemer J; Dührsen U; Meissner J; Viardot A; Eich H; Baues C; Diehl V; Rosenwald A; von Tresckow B; Dietlein M; Borchmann P; Engert A
    J Clin Oncol; 2019 Nov; 37(31):2835-2845. PubMed ID: 31498753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.